We described prevalence estimates of high-risk human papillomavirus (HR-HPV), HPV types 16 and 18, and abnormal Papanicolaou (Pap) smear tests among American Indian/Alaska Native (AI/AN) women compared with women of other races/ethnicities.
Methods.
A total of 9,706 women presenting for cervical screening in a sentinel network of 26 clinics (sexually transmitted disease, family planning, and primary care) received Pap smears and HR-HPV type-specific testing. We compared characteristics of 291 women self-identified as AI/AN with other racial/ethnic minority groups.
Results.
In our population, AI/AN and non-Hispanic white (NHW women had similar age- and clinic-adjusted prevalences of HR-HPV (29.1%, 95% confidence interval [CI] 23.9, 34.3 for AI/AN women vs. 25.8%, 95% CI 24.4, 27.2 for NHW women), HPV 16 and 18 (6.7%, 95% CI 3.9, 9.6 for AI/AN women vs. 8.8%, 95% CI 7.9, 9.7 for NHW women), and abnormal Pap smear test results (16%, 95% CI 11.7, 20.3 for AI/AN women vs. 14.9%, 95% CI 13.7, 16.0 for NHW women). AI/AN women had a higher prevalence of HR-HPV than Hispanic women, and a similar prevalence of HPV 16 and 18 as compared with Hispanic and African American women.
Conclusions.
We could not demonstrate differences in the prevalence of HR-HPV, HPV 16 and 18, or abnormal Pap smear test results between AI/AN and NHW women. This finding should improve confidence in the benefit of HPV vaccine and Pap smear screening in the AI/AN population as an effective strategy to reduce rates of cervical cancer.
References
1.
JemalASiegelRWardEHaoYXuJMurrayTCancer statistics, 2008. CA Cancer J Clin2008;58:71–96.
2.
EspeyDKWuXCSwanJWigginsCJimMAWardEAnnual report to the nation on the status of cancer, 1975–2004, featuring cancer in American Indians and Alaska Natives. Cancer2007;110:2119–52.
3.
BeckerTMEspeyDKLawsonHWSaraiyaMJimMAWaxmanAG. Regional differences in cervical cancer incidence among American Indians and Alaska Natives, 1999–2004. Cancer2008;113(5 Suppl):1234–43.
4.
EspeyDPaisanoRCobbN. Regional patterns and trends in cancer mortality among American Indians and Alaska Natives, 1990–2001. Cancer2005;103:1045–53.
5.
KilmerGRobertsHHughesELiYValluruBFanASurveillance of certain health behaviors and conditions among states and selected local areas—Behavior Risk Factor Surveillance System (BRFSS), United States, 2006. MMWR Surveill Summ2008;57(SS-7):1–188.
6.
BenardVBLeeNCPiperMRichardsonL. Race-specific results of Papanicolaou testing and the rate of cervical neoplasia in the National Breast and Cervical Cancer Early Detection Program, 1991–1998 (United States). Cancer Causes Control2001;12:61–8.
7.
BenardVBHoweWSaraiyaMHelselWLawsonHW. Assessment of follow-up for low-grade cytological abnormalities in the National Breast and Cervical Cancer Early Detection Program, 2000–2005. J Low Genit Tract Dis2008;12:300–6.
8.
WalboomersJMJacobsMVManosMMBoschFXKummerJAShahKVHuman papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol1999;189:12–9.
9.
BoschFXLorinczAMunozNMeijerCJShahKV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol2002;55:244–65.
10.
SebbelovAMDavidsonMKjaerS KrugerJensenHGregoireLHawkinsIComparison of human papillomavirus genotypes in archival cervical cancer specimens from Alaska Natives, Greenland natives and Danish Caucasians. Microbes Infect2000;2:121–6.
11.
BellMCSchmidt-GrimmingerDPatrickSRyschonTLinzLChauhanSC. There is a high prevalence of human papillomavirus infection in American Indian women of the Northern Plains. Gynecol Oncol2007;107:236–41.
12.
GarlandSMHernandez-AvilaMWheelerCMPerezGHarperDMLeodolterSQuadrivalent vaccine against human papillomavirus to prevent anogenital diseases. N Engl J Med2007;356:1928–43.
13.
Future II Study Group. Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N Engl J Med2007;356:1915–27.
14.
Toffolon-WeissMHaganKLestonJPetersonLProvostEHennessyT. Alaska Native parental attitudes on cervical cancer, HPV and the HPV vaccine. Int J Circumpolar Health2008;67:363–73.
15.
SapsisKFriedmanA. Preliminary findings from exploratory and materials testing focus groups with female caregivers of American Indian 11 and 12 year olds. Paper presented at the Annual Meeting of the National Coalition of STD Directors; 2008 Oct 21–24; Phoenix, Arizona.
DattaSDKoutskyLARatelleSUngerERShlayJMcClainTHuman papillomavirus infection and cervical cytology in women screened for cervical cancer in the United States, 2003–2005. Ann Intern Med2008;148:493–500.
18.
SAS Institute, Inc.SAS®: Version 8.2. Cary (NC): SAS Institute, Inc.; 2001.
19.
DavidsonMSchnitzerPGBulkowLRParkinsonAJSchlossMLFitzgeraldMAThe prevalence of cervical infection with human papillomaviruses and cervical dysplasia in Alaska Native women. J Infect Dis1994;169:792–800.
20.
BeckerTMWheelerCMMcGoughNSJordanSWDorinMMillerJ. Cervical papillomavirus infection and cervical dysplasia in Hispanic, Native American, and non-Hispanic white women in New Mexico. Am J Public Health1991;81:582–6.
21.
HubbardRA. Human papillomavirus testing methods. Arch Pathol Lab Med2003;127:940–5.
22.
OgunwoleSU. The American Indian and Alaska Native population: Census 2000 brief. Washington: Department of Commerce, Economics and Statistics Administration, Census Bureau (US); 2002. Also available from: URL: http://www.census.gov/prod/2002pubs/c2kbr01-15.pdf [cited 2009 Dec 22].
23.
Urban Indian Health Institute. The health status of urban American Indians and Alaska Natives: an analysis of select vital records and census data sources. Seattle: Urban Indian Health Institute; 2004.
24.
SugarmanJRSoderbergRGordonJERivaraFP. Racial misclassification of American Indians: its effect on injury rates in Oregon, 1989 through 1990. Am J Public Health1993;83:681–4.
25.
Stehr-GreenPBettlesJRobertsonLD. Effect of racial/ethnic misclassification of American Indians and Alaskan Natives on Washington State death certificates, 1989–1997. Am J Public Health2002;92:443–4.
26.
BeckerTMBettlesJLapidusJCampoJJohnsonCJShipleyDImproving cancer incidence estimates for American Indians and Alaska Natives in the Pacific Northwest. Am J Public Health2002;92:1469–71.
27.
Frost F, Taylor V, Fries E. Racial misclassification of Native Americans in a surveillance, epidemiology, and end results cancer registry. J Natl Cancer Inst1992;84:957–62.
28.
WigginsCLEspeyDKWingoPAKaurJSWilsonRTSwanJCancer among American Indians and Alaska Natives in the United States, 1999–2004. Cancer2008;113(5 Suppl):1142–52.
29.
AriasESchaumanWSEschbachKSorliePDBacklundE. The validity of race and Hispanic origin reporting on death certificates in the United States. Vital Health Stat 22008(148)
30.
SwanJBreenNBurhansstipanovLSatterDEDavisWWMcNeelTCancer screening and risk factor rates among American Indians. Am J Public Health2006;96:340–50.
31.
Centers for Disease Control and Prevention (US). United States cancer statistics: 1999–2006 incidence and mortality Web-based report. Atlanta: Department of Health and Human Services, CDC, National Cancer Institute (US); 2010. Also available from: URL: http://www.cdc.gov/uscs [cited 2010 Dec 10].
32.
EspeyDKWigginsCLJimMAMillerBAJohnsonCJBeckerTM. Methods for improving cancer surveillance data in American Indian and Alaska Native populations. Cancer2008;113(5 Suppl):1120–30.
33.
BenardVBCoughlinSSThompsonTRichardsonLC. Cervical cancer incidence in the United States by area of residence, 1998–2001. Obstet Gynecol2007;110:681–6.
34.
CliffordGMGallusSHerreroRMunozNSnijdersPJVaccarellaSWorldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet2005;366:991–8.
35.
CliffordGMRanaRKFranceschiSSmithJSGoughGPimentaJM. Human papillomavirus genotype distribution in low-grade cervical lesions: comparison by geographic region and with cervical cancer. Cancer Epidemiol Biomarkers Prev2005;14:1157–64.
36.
WardEHalpernMSchragNCokkinidesVDeSantisCBandiPAssociation of insurance with cancer care utilization and outcomes. CA Cancer J Clin2008;58:9–31.
